CD79A and infection: Only 24% (12/50) of pre-pandemic HBM samples and 22.9% (47/209) of the HBM from vaccinated individuals without self-reported infection were above the N IgA cutoff, while in most of the post-pandemic HBM samples with self-reported infection, 70.4% (19/27) were above the N IgA positivity cutoff.